{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:15:33Z","timestamp":1792782933016,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272045"],"award-info":[{"award-number":["82272045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Foundation of the National Clinical Research Center for Geriatric Diseases","award":["2020LNJJ01"],"award-info":[{"award-number":["2020LNJJ01"]}],"id":[{"id":"https:\/\/ror.org\/03ddkvp86","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Key Program of Ministry of Industry and Information Technology of China","award":["CEIEC-2022-ZM02-0219"],"award-info":[{"award-number":["CEIEC-2022-ZM02-0219"]}],"id":[{"id":"https:\/\/ror.org\/0385nmy68","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022 JJ30936"],"award-info":[{"award-number":["2022 JJ30936"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00259-026-07779-5","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:23:11Z","timestamp":1770596591000},"page":"3985-3998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond nigrostriatal dopamine transporter loss: whole-brain DAT depletion patterns discriminate PD phenotypes"],"prefix":"10.1007","volume":"53","author":[{"given":"Jian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenna","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoke","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beisha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0998-8943","authenticated-orcid":false,"given":"Shuo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"7779_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of parkinson\u2019s disease. Lancet Neurol. 2021;20:385\u201397. https:\/\/doi.org\/10.1016\/s1474-4422(21)00030-2.","journal-title":"Lancet Neurol"},{"key":"7779_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s1474-4422(18)30499-x","volume":"18","author":"regional Global","year":"2019","unstructured":"Global regional, national burden of neurological disorders. 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18:459\u201380. https:\/\/doi.org\/10.1016\/s1474-4422(18)30499-x.","journal-title":"Lancet Neurol"},{"key":"7779_CR3","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/mds.27195","volume":"32","author":"A Fasano","year":"2017","unstructured":"Fasano A, Canning CG, Hausdorff JM, Lord S, Rochester L. Falls in parkinson\u2019s disease: a complex and evolving picture. Mov Disord. 2017;32:1524\u201336. https:\/\/doi.org\/10.1002\/mds.27195.","journal-title":"Mov Disord"},{"key":"7779_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.parkreldis.2016.04.027","volume":"28","author":"T Simuni","year":"2016","unstructured":"Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Tanner C, Marek K. How stable are parkinson\u2019s disease subtypes in de novo patients: analysis of the PPMI cohort? Parkinsonism Relat Disord. 2016;28:62\u20137. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.04.027.","journal-title":"Parkinsonism Relat Disord"},{"key":"7779_CR5","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1212\/wnl.40.10.1529","volume":"40","author":"J Jankovic","year":"1990","unstructured":"Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, et al. Variable expression of parkinson\u2019s disease: a base-line analysis of the DATATOP cohort. The Parkinson study group. Neurology. 1990;40:1529\u201334. https:\/\/doi.org\/10.1212\/wnl.40.10.1529.","journal-title":"Neurology"},{"key":"7779_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.tins.2013.06.003","volume":"36","author":"L Brichta","year":"2013","unstructured":"Brichta L, Greengard P, Flajolet M. Advances in the Pharmacological treatment of parkinson\u2019s disease: targeting neurotransmitter systems. Trends Neurosci. 2013;36:543\u201354. https:\/\/doi.org\/10.1016\/j.tins.2013.06.003.","journal-title":"Trends Neurosci"},{"key":"7779_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1468-1331.2009.02900.x","volume":"17","author":"P Barone","year":"2010","unstructured":"Barone P. Neurotransmission in parkinson\u2019s disease: beyond dopamine. Eur J Neurol. 2010;17:364\u201376. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02900.x.","journal-title":"Eur J Neurol"},{"key":"7779_CR8","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/mds.23468","volume":"26","author":"C Eggers","year":"2011","unstructured":"Eggers C, Kahraman D, Fink GR, Schmidt M, Timmermann L. Akinetic-rigid and tremor-dominant parkinson\u2019s disease patients show different patterns of FP-CIT single photon emission computed tomography. Mov Disord. 2011;26:416\u201323. https:\/\/doi.org\/10.1002\/mds.23468.","journal-title":"Mov Disord"},{"key":"7779_CR9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1468-1331.2009.02898.x","volume":"17","author":"C Rossi","year":"2010","unstructured":"Rossi C, Frosini D, Volterrani D, De Feo P, Unti E, Nicoletti V, et al. Differences in nigro-striatal impairment in clinical variants of early Parkinson\u2019s disease: evidence from a FP-CIT SPECT study. Eur J Neurol. 2010;17:626\u201330. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02898.x.","journal-title":"Eur J Neurol"},{"key":"7779_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrn.2016.165","volume":"18","author":"M Morales","year":"2017","unstructured":"Morales M, Margolis EB. Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat Rev Neurosci. 2017;18:73\u201385. https:\/\/doi.org\/10.1038\/nrn.2016.165.","journal-title":"Nat Rev Neurosci"},{"key":"7779_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature11740","volume":"493","author":"KM Tye","year":"2013","unstructured":"Tye KM, Mirzabekov JJ, Warden MR, Ferenczi EA, Tsai HC, Finkelstein J, et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature. 2013;493:537\u201341. https:\/\/doi.org\/10.1038\/nature11740.","journal-title":"Nature"},{"key":"7779_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","volume":"30","author":"A Bj\u00f6rklund","year":"2007","unstructured":"Bj\u00f6rklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci. 2007;30:194\u2013202. https:\/\/doi.org\/10.1016\/j.tins.2007.03.006.","journal-title":"Trends Neurosci"},{"key":"7779_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/cne.1092","volume":"432","author":"DA Lewis","year":"2001","unstructured":"Lewis DA, Melchitzky DS, Sesack SR, Whitehead RE, Auh S, Sampson A. Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J Comp Neurol. 2001;432:119\u201336. https:\/\/doi.org\/10.1002\/cne.1092.","journal-title":"J Comp Neurol"},{"key":"7779_CR14","doi-asserted-by":"publisher","first-page":"38070","DOI":"10.1038\/srep38070","volume":"6","author":"SJ Son","year":"2016","unstructured":"Son SJ, Kim M, Park H. Imaging analysis of parkinson\u2019s disease patients using SPECT and tractography. Sci Rep. 2016;6:38070. https:\/\/doi.org\/10.1038\/srep38070.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"7779_CR15","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1038\/ijo.2016.9","volume":"40","author":"D Benton","year":"2016","unstructured":"Benton D, Young HA. A meta-analysis of the relationship between brain dopamine receptors and obesity: a matter of changes in behavior rather than food addiction? Int J Obes (Lond). 2016;40(Suppl 1):S12\u201321. https:\/\/doi.org\/10.1038\/ijo.2016.9.","journal-title":"Int J Obes (Lond)"},{"key":"7779_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1195577","volume":"14","author":"F Kangli","year":"2023","unstructured":"Kangli F, Hongguang Z, Yinghua L, Xiaoxiao D, Yuyin D, Lulu G, et al. Characteristics and influencing factors of (11)C-CFT PET imaging in patients with early and late onset Parkinson\u2019s disease. Front Neurol. 2023;14:1195577. https:\/\/doi.org\/10.3389\/fneur.2023.1195577.","journal-title":"Front Neurol"},{"key":"7779_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/RLU.0b013e31824c5fae","volume":"37","author":"T Huang","year":"2012","unstructured":"Huang T, Wang H, Tang G, Liang X, Shi X, Zhang X. The influence of residual nor-\u03b2-CFT in 11C CFT injection on the Parkinson disease diagnosis: a 11C CFT PET study. Clin Nucl Med. 2012;37:743\u20137. https:\/\/doi.org\/10.1097\/RLU.0b013e31824c5fae.","journal-title":"Clin Nucl Med"},{"key":"7779_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/mdc3.13107","volume":"8","author":"JT Boonstra","year":"2021","unstructured":"Boonstra JT, Michielse S, Temel Y, Hoogland G, Jahanshahi A. Neuroimaging detectable differences between Parkinson\u2019s disease motor subtypes: a systematic review. Mov Disord Clin Pract. 2021;8:175\u201392. https:\/\/doi.org\/10.1002\/mdc3.13107.","journal-title":"Mov Disord Clin Pract"},{"key":"7779_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00786-z","volume":"10","author":"X Du","year":"2024","unstructured":"Du X, Zhao H, Li Y, Dai Y, Gao L, Li Y, et al. The value of PET\/CT in the diagnosis and differential diagnosis of Parkinson\u2019s disease: a dual-tracer study. NPJ Parkinsons Dis. 2024;10:171. https:\/\/doi.org\/10.1038\/s41531-024-00786-z.","journal-title":"NPJ Parkinsons Dis"},{"key":"7779_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/1531-8249(199905)45:5<601::AID-ANA8>3.0.CO;2-0","volume":"45","author":"Y Ouchi","year":"1999","unstructured":"Ouchi Y, Yoshikawa E, Okada H, Futatsubashi M, Sekine Y, Iyo M, et al. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early parkinson\u2019s disease: compartment analysis for beta-CFT binding with positron emission tomography. Ann Neurol. 1999;45:601\u201310.","journal-title":"Ann Neurol"},{"key":"7779_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00259-023-06402-1","volume":"51","author":"S Feng","year":"2023","unstructured":"Feng S, Ge J, Zhao S, Xu Q, Lin H, Li X, et al. Dopaminergic damage pattern predicts phenoconversion time in isolated rapid eye movement sleep behavior disorder. Eur J Nucl Med Mol Imaging. 2023;51:159\u201367. https:\/\/doi.org\/10.1007\/s00259-023-06402-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7779_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00377-w","volume":"8","author":"S Basaia","year":"2022","unstructured":"Basaia S, Agosta F, Francia A, Cividini C, Balestrino R, Stojkovic T, et al. Cerebro-cerebellar motor networks in clinical subtypes of Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022;8:113. https:\/\/doi.org\/10.1038\/s41531-022-00377-w.","journal-title":"NPJ Parkinsons Dis"},{"key":"7779_CR23","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1038\/s41380-020-0770-0","volume":"26","author":"M Filippi","year":"2021","unstructured":"Filippi M, Basaia S, Sarasso E, Stojkovic T, Stankovic I, Fontana A, et al. Longitudinal brain connectivity changes and clinical evolution in Parkinson\u2019s disease. Mol Psychiatry. 2021;26:5429\u201340. https:\/\/doi.org\/10.1038\/s41380-020-0770-0.","journal-title":"Mol Psychiatry"},{"key":"7779_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: comparison with the unified Parkinson\u2019s disease rating scale. Mov Disord. 2013;28:668\u201370. https:\/\/doi.org\/10.1002\/mds.25383.","journal-title":"Mov Disord"},{"key":"7779_CR25","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1007\/s00259-022-05752-6","volume":"49","author":"T Zhang","year":"2022","unstructured":"Zhang T, Nie B, Liu H, Shan B. Unified spatial normalization method of brain PET images using adaptive probabilistic brain atlas. Eur J Nucl Med Mol Imaging. 2022;49:3073\u201385. https:\/\/doi.org\/10.1007\/s00259-022-05752-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7779_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2023-101112","volume":"36","author":"J Hou","year":"2023","unstructured":"Hou J, Xiao Q, Zhou M, Xiao L, Yuan M, Zhong N, et al. Lower synaptic density associated with gaming disorder: an (18)F-SynVesT-1 PET imaging study. Gen Psychiatr. 2023;36:e101112. https:\/\/doi.org\/10.1136\/gpsych-2023-101112.","journal-title":"Gen Psychiatr"},{"key":"7779_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2025.05.013","author":"G Zieli\u0144ski","year":"2025","unstructured":"Zieli\u0144ski G. Effect size guidelines for individual and group differences in physiotherapy. Arch Phys Med Rehabil. 2025. https:\/\/doi.org\/10.1016\/j.apmr.2025.05.013.","journal-title":"Arch Phys Med Rehabil"},{"key":"7779_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9.","journal-title":"Neurobiol Aging"},{"key":"7779_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","volume":"8","author":"RL Doty","year":"2012","unstructured":"Doty RL. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol. 2012;8:329\u201339. https:\/\/doi.org\/10.1038\/nrneurol.2012.80.","journal-title":"Nat Rev Neurol"},{"key":"7779_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.04.025","volume":"236","author":"CA Brown","year":"2012","unstructured":"Brown CA, Campbell MC, Karimi M, Tabbal SD, Loftin SK, Tian LL, et al. Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys. Exp Neurol. 2012;236:190\u20137. https:\/\/doi.org\/10.1016\/j.expneurol.2012.04.025.","journal-title":"Exp Neurol"},{"key":"7779_CR31","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/mds.20897","volume":"21","author":"G Alves","year":"2006","unstructured":"Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson\u2019s disease. Mov Disord. 2006;21:1123\u201330. https:\/\/doi.org\/10.1002\/mds.20897.","journal-title":"Mov Disord"},{"key":"7779_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096629","volume":"9","author":"C Eggers","year":"2014","unstructured":"Eggers C, Schwartz F, Pedrosa DJ, Kracht L, Timmermann L. Parkinson\u2019s disease subtypes show a specific link between dopaminergic and glucose metabolism in the striatum. PLoS One. 2014;9:e96629. https:\/\/doi.org\/10.1371\/journal.pone.0096629.","journal-title":"PLoS One"},{"key":"7779_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/cns.13259","volume":"26","author":"B Shen","year":"2020","unstructured":"Shen B, Pan Y, Jiang X, Wu Z, Zhu J, Dong J, et al. Altered putamen and cerebellum connectivity among different subtypes of Parkinson\u2019s disease. CNS Neurosci Ther. 2020;26:207\u201314. https:\/\/doi.org\/10.1111\/cns.13259.","journal-title":"CNS Neurosci Ther"},{"key":"7779_CR34","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.2402638","volume":"249","author":"H Bergman","year":"1990","unstructured":"Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science. 1990;249:1436\u20138. https:\/\/doi.org\/10.1126\/science.2402638.","journal-title":"Science"},{"key":"7779_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/cns.12464","volume":"21","author":"HM Chen","year":"2015","unstructured":"Chen HM, Wang ZJ, Fang JP, Gao LY, Ma LY, Wu T, et al. Different patterns of spontaneous brain activity between tremor-dominant and postural instability\/gait difficulty subtypes of Parkinson\u2019s disease: a resting-state fMRI study. CNS Neurosci Ther. 2015;21:855\u201366. https:\/\/doi.org\/10.1111\/cns.12464.","journal-title":"CNS Neurosci Ther"},{"key":"7779_CR36","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/s1474-4422(10)70216-7","volume":"9","author":"A Iranzo","year":"2010","unstructured":"Iranzo A, Lome\u00f1a F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. Lancet Neurol. 2010;9:1070\u20137. https:\/\/doi.org\/10.1016\/s1474-4422(10)70216-7.","journal-title":"Lancet Neurol"},{"key":"7779_CR37","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/jnnp.64.3.314","volume":"64","author":"PK Morrish","year":"1998","unstructured":"Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ. Measuring the rate of progression and estimating the preclinical period of Parkinson\u2019s disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry. 1998;64:314\u20139. https:\/\/doi.org\/10.1136\/jnnp.64.3.314.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7779_CR38","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2165\/00003495-200262050-00005","volume":"62","author":"AD Korczyn","year":"2002","unstructured":"Korczyn AD, Nussbaum M. Emerging therapies in the pharmacological treatment of Parkinson\u2019s disease. Drugs. 2002;62:775\u201386. https:\/\/doi.org\/10.2165\/00003495-200262050-00005.","journal-title":"Drugs"},{"key":"7779_CR39","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182a9f558","volume":"81","author":"NI Bohnen","year":"2013","unstructured":"Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJ, et al. Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology. 2013;81:1611\u20136. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a9f558.","journal-title":"Neurology"},{"key":"7779_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhae270","author":"M Conti","year":"2024","unstructured":"Conti M, Garasto E, Bovenzi R, Ferrari V, Mercuri NB, Di Giuliano F, et al. Insular and limbic abnormal functional connectivity in early-stage Parkinson\u2019s disease patients with autonomic dysfunction. Cereb Cortex. 2024. https:\/\/doi.org\/10.1093\/cercor\/bhae270.","journal-title":"Cereb Cortex"},{"key":"7779_CR41","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s13311-020-00894-7","volume":"17","author":"C Marras","year":"2020","unstructured":"Marras C, Chaudhuri KR, Titova N, Mestre TA. Therapy of Parkinson\u2019s disease subtypes. Neurotherapeutics. 2020;17:1366\u201377. https:\/\/doi.org\/10.1007\/s13311-020-00894-7.","journal-title":"Neurotherapeutics"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07779-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07779-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07779-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:26:08Z","timestamp":1777274768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07779-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["7779"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07779-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Review Board of Xiangya Hospital, Central South University and the requirement for written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}